The Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price fell 1.39% after reporting its profit result for the full year to 31 March 2018, according to Yahoo! Finance.
Fisher & Paykel Healthcare describes itself as a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, and the treatment of obstructive sleep.
Here are some of the highlights from FPH’s full-year result:
- Net profit grew by 12% to NZ$190.2 million
- Revenue grew by 10% to NZ$980.8 million
- Research & Development investment increased by 10%
- Final dividend increased by 11% to 12.5 cents per share
Managing Director and CEO Lewis Gradon said, “Our consistent long term strategy has again delivered strong revenue and earnings growth over the past financial year and, over this same time period, our products and systems were used in the treatment of an estimated 13 million patients around the world.”
According to Fisher & Paykel Healthcare, its hospital product group grew revenue by 14% to NZ$572.1 million and the homecare product revenue grew by 4% to NZ$398.1 million.
Want healthy updates about investing?
Do you like investing but want to learn more? It’s free to join The Rask Group’s Investor Club Newsletter. It’s a regular (usually weekly) news and educational update on financial markets, investing and unique strategies. Join today and get ready to laugh and learn.